Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia Francisco Javier PeñalverAlberto Alvarez-Larránon behalf of the Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA Original Article 05 June 2010 Pages: 1073 - 1080
Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cells Seiichi OkabeTetsuzo TauchiKazuma Ohyashiki Original Article 20 June 2010 Pages: 1081 - 1087
Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro Jia-Jun LiuWen-Da LiuRen-Wei Huang Original Article 30 May 2010 Pages: 1089 - 1097
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib Baijun FangNing LiRobert Chunhua Zhao Original Article 25 May 2010 Pages: 1099 - 1105
A systematic review and meta-analysis of rituximab-based immunochemotherapy for subtypes of diffuse large B cell lymphoma Cheng FangWei XuJian-Yong Li Original Article 25 May 2010 Pages: 1107 - 1113
Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells Monika PodhoreckaDorota HalickaAnna Dmoszynska Original Article Open access 25 May 2010 Pages: 1115 - 1124
Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors Thomas DeckerChristian BognerIngo Ringshausen Original Article 11 June 2010 Pages: 1125 - 1132
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin Gabriele BudaDeborah RicciRobert Z. Orlowski Original Article Open access 08 June 2010 Pages: 1133 - 1140
Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies Emmanouil NikolousisSandeep NagraDonald Milligan Original Article 11 June 2010 Pages: 1141 - 1145
Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders Ana I. AntónRocio González-ConejeroDiego Mezzano Original Article 09 June 2010 Pages: 1147 - 1154
Evaluation of coagulation kinetics using thromboelastometry—methodologic influence of activator and test medium Benny SørensenChristian Fenger-EriksenJørgen Ingerslev Original Article 18 May 2010 Pages: 1155 - 1161
Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia Ki-Ho ParkOh-Hyun ChoSung-Han Kim Original Article 24 June 2010 Pages: 1163 - 1169
Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilli Cheol-In KangDoo Ryeon ChungKorean Network for Study of Infectious Diseases (KONSID) Letter to the Editor 24 February 2010 Pages: 1171 - 1173
Gastric mucosa-associated lymphoid tissue lymphoma complicated with hemophagocytic syndrome in an elderly woman Hitoshi OhnoKengo Takimoto Letter to the Editor 02 March 2010 Pages: 1175 - 1176
Combining two orally active iron chelators for thalassemia Vasilios BerdoukasSusan CarsonThomas Coates Letter to the Editor 10 March 2010 Pages: 1177 - 1178
Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease Niall F. DavisBarry B. McGuireJohn M. Fitzpatrick Letter to the Editor 01 April 2010 Pages: 1179 - 1180
Pancytopenia secondary to hypopituitarism may just be due to hypothyroidism alone Anselm Chi-wai Lee Letter to the Editor 23 March 2010 Pages: 1181 - 1181
Extramedullary manifestations of multiple myeloma in the thyroid gland and in the lungs: excellent response to therapy Fabia WeisserChristiane ReuterChristian Taverna Letter to the Editor Open access 10 April 2010 Pages: 1183 - 1184